
جرين 250 وحدة دولية فيال
blood-coagulation factor viiiThe published official price. Pharmacies may differ slightly.
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Used for prevention and treatment of bleeding episodes in patients with hemophilia A.
Contraindicated in patients with known hypersensitivity to factor VIII products or formulation components.
Injection-site reactions, headache, fever, hypersensitivity reactions, and inhibitor development may occur.
Monitor for hypersensitivity reactions and development of factor VIII inhibitors.
Replacement therapy that restores deficient coagulation factor VIII activity and promotes normal clot formation.
Store refrigerated according to manufacturer instructions.